SERUM ALBUMIN LEVELS AS A PROGNOSTIC MARKER IN ARTERIOVENOUS FISTULA FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE CENTRE – A CROSS SECTIONAL STUDY
Genetics and Molecular Research · 2026-07-27
DOI: 10.4238/5bmtb107 ↗At a glance
Journal article in Genetics and Molecular Research, published online on 2026-07-27. Written by Dr M Aravind Venkat and 2 co-authors. The full text is freely available (open access, CC BY-SA 4.0).
Abstract (original language)
CKD is a significant community well-being concern in developing nations like India, where late diagnosis and insufficient resources result in unfavourable outcomes. Hemodialysis constitutes the primary renal replacement treatment, and arteriovenous fistulas (AVFs) are the optimal vascular access because of improved patency and reduced complications. Nevertheless, up to 40 per cent of patients have AVF failure due to poor maturation or early dysfunction. Negative acute phase proteins like serum albumin indicate the nutritional and inflammatory conditions in CKD. Hypoalbuminemia is frequent because of malnutrition, inflammation and protein losses, and is linked to poor tissue repair, endothelial dysfunction and poor vascular integrity, which can have negative implications on AVF outcomes.
Cite
APA
Venkat, D. M. A., A, D. R., & N, D. P. K. (2026). SERUM ALBUMIN LEVELS AS A PROGNOSTIC MARKER IN ARTERIOVENOUS FISTULA FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE CENTRE – A CROSS SECTIONAL STUDY. Genetics and Molecular Research. https://doi.org/10.4238/5bmtb107
Vancouver
Venkat DMA, A DR, N DPK. SERUM ALBUMIN LEVELS AS A PROGNOSTIC MARKER IN ARTERIOVENOUS FISTULA FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE CENTRE – A CROSS SECTIONAL STUDY. Genetics and Molecular Research. 2026. doi:10.4238/5bmtb107
BibTeX
@article{Venkat2026,
author = {Venkat, Dr M Aravind and A, Dr Raveesha and N, Dr Prasanna Kumar},
title = {SERUM ALBUMIN LEVELS AS A PROGNOSTIC MARKER IN ARTERIOVENOUS FISTULA FAILURE IN CHRONIC KIDNEY DISEASE PATIENTS IN A TERTIARY CARE CENTRE – A CROSS SECTIONAL STUDY},
journal = {Genetics and Molecular Research},
year = {2026},
doi = {10.4238/5bmtb107}
}
EUVIMED